{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38001575", "DateRevised": {"Year": "2023", "Month": "11", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "07"}], "Language": ["eng"], "ELocationID": ["5315", "10.3390/cancers15225315"], "Journal": {"ISSN": "2072-6694", "JournalIssue": {"Volume": "15", "Issue": "22", "PubDate": {"Year": "2023", "Month": "Nov", "Day": "07"}}, "Title": "Cancers", "ISOAbbreviation": "Cancers (Basel)"}, "ArticleTitle": "Thinking (Metastasis) outside the (Primary Tumor) Box.", "Abstract": {"AbstractText": ["The metastasis of tumor cells into vital organs is a major cause of death from diverse types of malignancies [...]."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}], "LastName": "Jiang", "ForeName": "Zhe", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}], "LastName": "Ju", "ForeName": "Young-Jun", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}], "LastName": "Ali", "ForeName": "Amjad", "Initials": "A"}, {"Identifier": ["0000-0002-3443-3088"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}, {"Identifier": [], "Affiliation": "Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada."}], "LastName": "Chung", "ForeName": "Philip E D", "Initials": "PED"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}], "LastName": "Wang", "ForeName": "Dong-Yu", "Initials": "DY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada."}], "LastName": "Liu", "ForeName": "Jeff C", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}], "LastName": "Li", "ForeName": "Huiqin", "Initials": "H"}, {"Identifier": ["0000-0002-1479-7570"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}, {"Identifier": [], "Affiliation": "Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada."}], "LastName": "Vorobieva", "ForeName": "Ioulia", "Initials": "I"}, {"Identifier": ["0000-0003-0568-9372"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}], "LastName": "Mwewa", "ForeName": "Ethel", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}, {"Identifier": [], "Affiliation": "Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada."}], "LastName": "Ghanbari-Azarnier", "ForeName": "Ronak", "Initials": "R"}, {"Identifier": ["0009-0003-7880-7584"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}, {"Identifier": [], "Affiliation": "Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada."}], "LastName": "Shrestha", "ForeName": "Mariusz", "Initials": "M"}, {"Identifier": ["0000-0002-9020-6074"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "The Natural Products Research Center of Guizhou Province, Guiyang 550014, China."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Toronto General Research Institute-University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada."}, {"Identifier": [], "Affiliation": "Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada."}, {"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}], "PublicationTypeList": ["Editorial"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cancers (Basel)", "NlmUniqueID": "101526829", "ISSNLinking": "2072-6694"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chaffer C.L., San Juan B.P., Lim E., Weinberg R.A. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35:645\u2013654. doi: 10.1007/s10555-016-9648-7.", "ArticleIdList": ["10.1007/s10555-016-9648-7", "27878502"]}, {"Citation": "Scheid A.D., Beadnell T.C., Welch D.R. Roles of mitochondria in the hallmarks of metastasis. Br. J. Cancer. 2021;124:124\u2013135. doi: 10.1038/s41416-020-01125-8.", "ArticleIdList": ["10.1038/s41416-020-01125-8", "PMC7782743", "33144695"]}, {"Citation": "Zacksenhaus E., Egan S.E. Progression to Metastasis of Solid Cancer. Cancers. 2021;13:717. doi: 10.3390/cancers13040717.", "ArticleIdList": ["10.3390/cancers13040717", "PMC7916396", "33578666"]}, {"Citation": "Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat. Rev. Cancer. 2004;4:448\u2013456. doi: 10.1038/nrc1370.", "ArticleIdList": ["10.1038/nrc1370", "15170447"]}, {"Citation": "Bernards R., Weinberg R.A. A progression puzzle. Nature. 2002;418:823. doi: 10.1038/418823a.", "ArticleIdList": ["10.1038/418823a", "12192390"]}, {"Citation": "Siegel M.B., He X., Hoadley K.A., Hoyle A., Pearce J.B., Garrett A.L., Kumar S., Moylan V.J., Brady C.M., Van Swearingen A.E., et al. Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. J. Clin. Investig. 2018;128:1371\u20131383. doi: 10.1172/JCI96153.", "ArticleIdList": ["10.1172/JCI96153", "PMC5873890", "29480819"]}, {"Citation": "van Dessel L.F., van Riet J., Smits M., Zhu Y., Hamberg P., van der Heijden M.S., Bergman A.M., van Oort I.M., de Wit R., Voest E.E., et al. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact. Nat. Commun. 2019;10:5251. doi: 10.1038/s41467-019-13084-7.", "ArticleIdList": ["10.1038/s41467-019-13084-7", "PMC6868175", "31748536"]}, {"Citation": "Robinson D.R., Wu Y.M., Lonigro R.J., Vats P., Cobain E., Everett J., Cao X., Rabban E., Kumar-Sinha C., Raymond V., et al. Integrative clinical genomics of metastatic cancer. Nature. 2017;548:297\u2013303. doi: 10.1038/nature23306.", "ArticleIdList": ["10.1038/nature23306", "PMC5995337", "28783718"]}, {"Citation": "Savas P., Teo Z.L., Lefevre C., Flensburg C., Caramia F., Alsop K., Mansour M., Francis P.A., Thorne H.A., Silva M.J., et al. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program \u201cCASCADE\u201d. PLoS Med. 2016;13:e1002204. doi: 10.1371/journal.pmed.1002204.", "ArticleIdList": ["10.1371/journal.pmed.1002204", "PMC5189956", "28027312"]}, {"Citation": "Paul M.R., Pan T.C., Pant D.K., Shih N.N., Chen Y., Harvey K.L., Solomon A., Lieberman D., Morrissette J.J., Soucier-Ernst D., et al. Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets. J. Clin. Investig. 2020;130:4252\u20134265. doi: 10.1172/JCI129941.", "ArticleIdList": ["10.1172/JCI129941", "PMC7410083", "32657779"]}, {"Citation": "Wu X., Northcott P.A., Dubuc A., Dupuy A.J., Shih D.J., Witt H., Croul S., Bouffet E., Fults D.W., Eberhart C.G., et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature. 2012;482:529\u2013533. doi: 10.1038/nature10825.", "ArticleIdList": ["10.1038/nature10825", "PMC3288636", "22343890"]}, {"Citation": "Hakem A., Sanchez-Sweatman O., You-Ten A., Duncan G., Wakeham A., Khokha R., Mak T.W. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 2005;19:1974\u20131979. doi: 10.1101/gad.1310805.", "ArticleIdList": ["10.1101/gad.1310805", "PMC1199568", "16107613"]}, {"Citation": "Ishaque N., Abba M.L., Hauser C., Patil N., Paramasivam N., Huebschmann D., Leupold J.H., Balasubramanian G.P., Kleinheinz K., Toprak U.H., et al. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer. Nat. Commun. 2018;9:4782. doi: 10.1038/s41467-018-07041-z.", "ArticleIdList": ["10.1038/s41467-018-07041-z", "PMC6235880", "30429477"]}, {"Citation": "Nguyen D.X., Bos P.D., Massague J. Metastasis: From dissemination to organ-specific colonization. Nat. Rev. Cancer. 2009;9:274\u2013284. doi: 10.1038/nrc2622.", "ArticleIdList": ["10.1038/nrc2622", "19308067"]}, {"Citation": "Nguyen B., Fong C., Luthra A., Smith S.A., DiNatale R.G., Nandakumar S., Walch H., Chatila W.K., Madupuri R., Kundra R., et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell. 2022;185:563\u2013575.e511. doi: 10.1016/j.cell.2022.01.003.", "ArticleIdList": ["10.1016/j.cell.2022.01.003", "PMC9147702", "35120664"]}, {"Citation": "Hessey S., Fessas P., Zaccaria S., Jamal-Hanjani M., Swanton C. Insights into the metastatic cascade through research autopsies. Trends. Cancer. 2023;9:490\u2013502. doi: 10.1016/j.trecan.2023.03.002.", "ArticleIdList": ["10.1016/j.trecan.2023.03.002", "37059687"]}, {"Citation": "Martinez-Jimenez F., Movasati A., Brunner S.R., Nguyen L., Priestley P., Cuppen E., Van Hoeck A. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. Nature. 2023;618:333\u2013341. doi: 10.1038/s41586-023-06054-z.", "ArticleIdList": ["10.1038/s41586-023-06054-z", "PMC10247378", "37165194"]}, {"Citation": "Morrissy A.S., Cavalli F.M.G., Remke M., Ramaswamy V., Shih D.J.H., Holgado B.L., Farooq H., Donovan L.K., Garzia L., Agnihotri S., et al. Spatial heterogeneity in medulloblastoma. Nat. Genet. 2017;49:780\u2013788. doi: 10.1038/ng.3838.", "ArticleIdList": ["10.1038/ng.3838", "PMC5553617", "28394352"]}, {"Citation": "Rossi D., Khiabanian H., Spina V., Ciardullo C., Bruscaggin A., Fama R., Rasi S., Monti S., Deambrogi C., De Paoli L., et al. Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. Blood. 2014;123:2139\u20132147. doi: 10.1182/blood-2013-11-539726.", "ArticleIdList": ["10.1182/blood-2013-11-539726", "PMC4017291", "24501221"]}, {"Citation": "Jiang Z., Deng T., Jones R., Li H., Herschkowitz J.I., Liu J.C., Weigman V.J., Tsao M.S., Lane T.F., Perou C.M., et al. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J. Clin. Investig. 2010;120:3296\u20133309. doi: 10.1172/JCI41490.", "ArticleIdList": ["10.1172/JCI41490", "PMC2929714", "20679727"]}, {"Citation": "Jiang Z., Ju Y., Ali A., Chung P.E.D., Skowron P., Wang D.Y., Shrestha M., Li H., Liu J.C., Vorobieva I., et al. Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer. Nat. Commun. 2023;14:4313. doi: 10.1038/s41467-023-39935-y.", "ArticleIdList": ["10.1038/s41467-023-39935-y", "PMC10354065", "37463901"]}, {"Citation": "Jiang Z., Jones R., Liu J.C., Deng T., Robinson T., Chung P.E., Wang S., Herschkowitz J.I., Egan S.E., Perou C.M., et al. RB1 and p53 at the crossroad of EMT and triple-negative breast cancer. Cell Cycle. 2011;10:1563\u20131570. doi: 10.4161/cc.10.10.15703.", "ArticleIdList": ["10.4161/cc.10.10.15703", "21502814"]}, {"Citation": "Zacksenhaus E., Shrestha M., Liu J.C., Vorobieva I., Chung P.E.D., Ju Y., Nir U., Jiang Z. Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis. Trends Cancer. 2017;3:768\u2013779. doi: 10.1016/j.trecan.2017.09.002.", "ArticleIdList": ["10.1016/j.trecan.2017.09.002", "29120753"]}, {"Citation": "Jiang Z., Li H., Schroer S.A., Voisin V., Ju Y., Pacal M., Erdmann N., Shi W., Chung P.E.D., Deng T., et al. Hypophosphorylated pRb knock-in mice exhibit hallmarks of aging and vitamin C-preventable diabetes. EMBO J. 2022;41:e106825. doi: 10.15252/embj.2020106825.", "ArticleIdList": ["10.15252/embj.2020106825", "PMC8844977", "35023164"]}, {"Citation": "Ciavarra G., Zacksenhaus E. Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift. J. Cell Biol. 2010;191:291\u2013301. doi: 10.1083/jcb.201005067.", "ArticleIdList": ["10.1083/jcb.201005067", "PMC2958467", "20937698"]}, {"Citation": "Robinson T.J., Liu J.C., Vizeacoumar F., Sun T., Maclean N., Egan S.E., Schimmer A.D., Datti A., Zacksenhaus E. RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs. PLoS ONE. 2013;8:e78641. doi: 10.1371/journal.pone.0078641.", "ArticleIdList": ["10.1371/journal.pone.0078641", "PMC3827056", "24265703"]}, {"Citation": "Shrestha M., Wang D.Y., Ben-David Y., Zacksenhaus E. CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer. Oncogenesis. 2023;12:29. doi: 10.1038/s41389-023-00475-1.", "ArticleIdList": ["10.1038/s41389-023-00475-1", "PMC10213015", "37230983"]}, {"Citation": "Jones R.A., Robinson T.J., Liu J.C., Shrestha M., Voisin V., Ju Y., Chung P.E., Pellecchia G., Fell V.L., Bae S., et al. RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. J. Clin. Investig. 2016;126:3739\u20133757. doi: 10.1172/JCI81568.", "ArticleIdList": ["10.1172/JCI81568", "PMC5096803", "27571409"]}, {"Citation": "Liu J.C., Granieri L., Shrestha M., Wang D.Y., Vorobieva I., Rubie E.A., Jones R., Ju Y., Pellecchia G., Jiang Z., et al. Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer. Cell Rep. 2018;23:112\u2013126. doi: 10.1016/j.celrep.2018.03.039.", "ArticleIdList": ["10.1016/j.celrep.2018.03.039", "PMC9357459", "29617654"]}, {"Citation": "Ho-Yen C.M., Jones J.L., Kermorgant S. The clinical and functional significance of c-Met in breast cancer: A review. Breast Cancer Res. 2015;17:52. doi: 10.1186/s13058-015-0547-6.", "ArticleIdList": ["10.1186/s13058-015-0547-6", "PMC4389345", "25887320"]}, {"Citation": "Singh S., Smith M.J. RAS GTPase signalling to alternative effector pathways. Biochem. Soc. Trans. 2020;48:2241\u20132252. doi: 10.1042/BST20200506.", "ArticleIdList": ["10.1042/BST20200506", "33125484"]}, {"Citation": "Liu W., Gajendran B., Sample K.M., Wang C., Hu A., Chen B., Li Y., Zacksenhaus E., Ben-David Y. A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer. Cancer Gene Ther. 2022;29:1590\u20131599. doi: 10.1038/s41417-022-00471-4.", "ArticleIdList": ["10.1038/s41417-022-00471-4", "35477769"]}, {"Citation": "Aceto N., Bardia A., Miyamoto D.T., Donaldson M.C., Wittner B.S., Spencer J.A., Yu M., Pely A., Engstrom A., Zhu H., et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110\u20131122. doi: 10.1016/j.cell.2014.07.013.", "ArticleIdList": ["10.1016/j.cell.2014.07.013", "PMC4149753", "25171411"]}, {"Citation": "Andrechek E.R., Cardiff R.D., Chang J.T., Gatza M.L., Acharya C.R., Potti A., Nevins J.R. Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. Proc. Natl. Acad. Sci. USA. 2009;106:16387\u201316392. doi: 10.1073/pnas.0901250106.", "ArticleIdList": ["10.1073/pnas.0901250106", "PMC2752567", "19805309"]}, {"Citation": "Gatza M.L., Lucas J.E., Barry W.T., Kim J.W., Wang Q., Crawford M.D., Datto M.B., Kelley M., Mathey-Prevot B., Potti A., et al. A pathway-based classification of human breast cancer. Proc. Natl. Acad. Sci. USA. 2010;107:6994\u20136999. doi: 10.1073/pnas.0912708107.", "ArticleIdList": ["10.1073/pnas.0912708107", "PMC2872436", "20335537"]}, {"Citation": "Wang D.Y., Gendoo D.M.A., Ben-David Y., Woodgett J.R., Zacksenhaus E. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling. Breast Cancer Res. 2019;21:18. doi: 10.1186/s13058-019-1098-z.", "ArticleIdList": ["10.1186/s13058-019-1098-z", "PMC6357448", "30704524"]}, {"Citation": "Wang D.Y., Jiang Z., Ben-David Y., Woodgett J.R., Zacksenhaus E. Molecular stratification within triple-negative breast cancer subtypes. Sci. Rep. 2019;9:19107. doi: 10.1038/s41598-019-55710-w.", "ArticleIdList": ["10.1038/s41598-019-55710-w", "PMC6911070", "31836816"]}, {"Citation": "Padua D., Massague J. Roles of TGFbeta in metastasis. Cell Res. 2009;19:89\u2013102. doi: 10.1038/cr.2008.316.", "ArticleIdList": ["10.1038/cr.2008.316", "19050696"]}, {"Citation": "Seoane J., Gomis R.R. TGF-beta Family Signaling in Tumor Suppression and Cancer Progression. Cold Spring Harb. Perspect. Biol. 2017;9:a022277. doi: 10.1101/cshperspect.a022277.", "ArticleIdList": ["10.1101/cshperspect.a022277", "PMC5710110", "28246180"]}, {"Citation": "Tian M., Schiemann W.P. The TGF-beta paradox in human cancer: An update. Future Oncol. 2009;5:259\u2013271. doi: 10.2217/14796694.5.2.259.", "ArticleIdList": ["10.2217/14796694.5.2.259", "PMC2710615", "19284383"]}, {"Citation": "Ali R., Wendt M.K. The paradoxical functions of EGFR during breast cancer progression. Signal Transduct. Target. Ther. 2017;2:16042. doi: 10.1038/sigtrans.2016.42.", "ArticleIdList": ["10.1038/sigtrans.2016.42", "PMC5397119", "28435746"]}, {"Citation": "Jones L.M., Broz M.L., Ranger J.J., Ozcelik J., Ahn R., Zuo D., Ursini-Siegel J., Hallett M.T., Krummel M., Muller W.J. STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis. Cancer Res. 2016;76:1416\u20131428. doi: 10.1158/0008-5472.CAN-15-2770.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-2770", "PMC5052827", "26719528"]}, {"Citation": "Ma J.H., Qin L., Li X. Role of STAT3 signaling pathway in breast cancer. Cell Commun. Signal. 2020;18:33. doi: 10.1186/s12964-020-0527-z.", "ArticleIdList": ["10.1186/s12964-020-0527-z", "PMC7048131", "32111215"]}, {"Citation": "Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science. 2009;324:1029\u20131033. doi: 10.1126/science.1160809.", "ArticleIdList": ["10.1126/science.1160809", "PMC2849637", "19460998"]}, {"Citation": "Ward P.S., Thompson C.B. Metabolic reprogramming: A cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21:297\u2013308. doi: 10.1016/j.ccr.2012.02.014.", "ArticleIdList": ["10.1016/j.ccr.2012.02.014", "PMC3311998", "22439925"]}, {"Citation": "Hoang-Minh L.B., Siebzehnrubl F.A., Yang C., Suzuki-Hatano S., Dajac K., Loche T., Andrews N., Schmoll Massari M., Patel J., Amin K., et al. Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma. EMBO J. 2018;37:e98772. doi: 10.15252/embj.201798772.", "ArticleIdList": ["10.15252/embj.201798772", "PMC6276884", "30322894"]}, {"Citation": "LeBleu V.S., O\u2019Connell J.T., Gonzalez Herrera K.N., Wikman H., Pantel K., Haigis M.C., de Carvalho F.M., Damascena A., Domingos Chinen L.T., Rocha R.M., et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 2014;16:992\u20131003. doi: 10.1038/ncb3039.", "ArticleIdList": ["10.1038/ncb3039", "PMC4369153", "25241037"]}, {"Citation": "Ocana O.H., Corcoles R., Fabra A., Moreno-Bueno G., Acloque H., Vega S., Barrallo-Gimeno A., Cano A., Nieto M.A. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012;22:709\u2013724. doi: 10.1016/j.ccr.2012.10.012.", "ArticleIdList": ["10.1016/j.ccr.2012.10.012", "23201163"]}, {"Citation": "Huang B., Lu M., Jolly M.K., Tsarfaty I., Onuchic J., Ben-Jacob E. The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition. Sci. Rep. 2014;4:6449. doi: 10.1038/srep06449.", "ArticleIdList": ["10.1038/srep06449", "PMC4171704", "25245029"]}, {"Citation": "Graziani V., Rodriguez-Hernandez I., Maiques O., Sanz-Moreno V. The amoeboid state as part of the epithelial-to-mesenchymal transition programme. Trends. Cell Biol. 2022;32:228\u2013242. doi: 10.1016/j.tcb.2021.10.004.", "ArticleIdList": ["10.1016/j.tcb.2021.10.004", "34836782"]}, {"Citation": "Aiello N.M., Maddipati R., Norgard R.J., Balli D., Li J., Yuan S., Yamazoe T., Black T., Sahmoud A., Furth E.E., et al. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Dev. Cell. 2018;45:681\u2013695.e684. doi: 10.1016/j.devcel.2018.05.027.", "ArticleIdList": ["10.1016/j.devcel.2018.05.027", "PMC6014628", "29920274"]}, {"Citation": "Rehman S.K., Haynes J., Collignon E., Brown K.R., Wang Y., Nixon A.M.L., Bruce J.P., Wintersinger J.A., Singh Mer A., Lo E.B.L., et al. Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy. Cell. 2021;184:226\u2013242.e221. doi: 10.1016/j.cell.2020.11.018.", "ArticleIdList": ["10.1016/j.cell.2020.11.018", "PMC8437243", "33417860"]}, {"Citation": "Hoshino A., Costa-Silva B., Shen T.L., Rodrigues G., Hashimoto A., Tesic Mark M., Molina H., Kohsaka S., Di Giannatale A., Ceder S., et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u2013335. doi: 10.1038/nature15756.", "ArticleIdList": ["10.1038/nature15756", "PMC4788391", "26524530"]}, {"Citation": "Lin D., Shen L., Luo M., Zhang K., Li J., Yang Q., Zhu F., Zhou D., Zheng S., Chen Y., et al. Circulating tumor cells: Biology and clinical significance. Signal Transduct. Target. Ther. 2021;6:404. doi: 10.1038/s41392-021-00817-8.", "ArticleIdList": ["10.1038/s41392-021-00817-8", "PMC8606574", "34803167"]}, {"Citation": "Mizuno M., Khaledian B., Maeda M., Hayashi T., Mizuno S., Munetsuna E., Watanabe T., Kono S., Okada S., Suzuki M., et al. Adipsin-Dependent Secretion of Hepatocyte Growth Factor Regulates the Adipocyte-Cancer Stem Cell Interaction. Cancers. 2021;13:4238. doi: 10.3390/cancers13164238.", "ArticleIdList": ["10.3390/cancers13164238", "PMC8393397", "34439392"]}, {"Citation": "Yang C., Tian G., Dajac M., Doty A., Wang S., Lee J.H., Rahman M., Huang J., Reynolds B.A., Sarkisian M.R., et al. Slow-Cycling Cells in Glioblastoma: A Specific Population in the Cellular Mosaic of Cancer Stem Cells. Cancers. 2022;14:1126. doi: 10.3390/cancers14051126.", "ArticleIdList": ["10.3390/cancers14051126", "PMC8909138", "35267434"]}, {"Citation": "Haist M., Stege H., Ebner R., Fleischer M.I., Loquai C., Grabbe S. The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study. Cancers. 2022;14:2082. doi: 10.3390/cancers14092082.", "ArticleIdList": ["10.3390/cancers14092082", "PMC9101790", "35565212"]}, {"Citation": "Gul D., Schweitzer A., Khamis A., Knauer S.K., Ding G.B., Freudelsperger L., Karampinis I., Strieth S., Hagemann J., Stauber R.H. Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer. Cancers. 2022;14:2337. doi: 10.3390/cancers14092337.", "ArticleIdList": ["10.3390/cancers14092337", "PMC9106029", "35565465"]}, {"Citation": "Lin C.Y., Song X., Ke Y., Raha A., Wu Y., Wasi M., Wang L., Geng F., You L. Yoda1 Enhanced Low-Magnitude High-Frequency Vibration on Osteocytes in Regulation of MDA-MB-231 Breast Cancer Cell Migration. Cancers. 2022;14:3395. doi: 10.3390/cancers14143395.", "ArticleIdList": ["10.3390/cancers14143395", "PMC9324638", "35884459"]}, {"Citation": "Ormseth B., Onuma A., Zhang H., Tsung A. The Hepatic Pre-Metastatic Niche. Cancers. 2022;14:3731. doi: 10.3390/cancers14153731.", "ArticleIdList": ["10.3390/cancers14153731", "PMC9367402", "35954395"]}, {"Citation": "Goyette M.A., Cote J.F. AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis. Cancers. 2022;14:466. doi: 10.3390/cancers14030466.", "ArticleIdList": ["10.3390/cancers14030466", "PMC8833413", "35158733"]}, {"Citation": "Krishnan R., Patel P.S., Hakem R. BRCA1 and Metastasis: Outcome of Defective DNA Repair. Cancers. 2021;14:108. doi: 10.3390/cancers14010108.", "ArticleIdList": ["10.3390/cancers14010108", "PMC8749860", "35008272"]}, {"Citation": "Gaebe K., Li A.Y., Das S. Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease. Cancers. 2021;13:5973. doi: 10.3390/cancers13235973.", "ArticleIdList": ["10.3390/cancers13235973", "PMC8656478", "34885083"]}, {"Citation": "Terceiro L.E.L., Edechi C.A., Ikeogu N.M., Nickel B.E., Hombach-Klonisch S., Sharif T., Leygue E., Myal Y. The Breast Tumor Microenvironment: A Key Player in Metastatic Spread. Cancers. 2021;13:4798. doi: 10.3390/cancers13194798.", "ArticleIdList": ["10.3390/cancers13194798", "PMC8507966", "34638283"]}, {"Citation": "Dankner M., Lam S., Degenhard T., Garzia L., Guiot M.C., Petrecca K., Siegel P.M. The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers. Cancers. 2021;13:732. doi: 10.3390/cancers13040732.", "ArticleIdList": ["10.3390/cancers13040732", "PMC7916586", "33578853"]}, {"Citation": "McDonald P.C., Dedhar S. New Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis. Cancers. 2022;14:3209. doi: 10.3390/cancers14133209.", "ArticleIdList": ["10.3390/cancers14133209", "PMC9264971", "35804980"]}, {"Citation": "Bonnelye E., Juarez P. Targeting Bone Metastasis in Cancers. Cancers. 2021;13:4490. doi: 10.3390/cancers13174490.", "ArticleIdList": ["10.3390/cancers13174490", "PMC8431367", "34503299"]}, {"Citation": "Makino T., Izumi K., Iwamoto H., Mizokami A. Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer. Cancers. 2021;13:4470. doi: 10.3390/cancers13174470.", "ArticleIdList": ["10.3390/cancers13174470", "PMC8430548", "34503280"]}, {"Citation": "Care A., Del Bufalo D., Facchiano A. Editorial on Special Issue \u201cAdvances and Novel Treatment Options in Metastatic Melanoma\u201d. Cancers. 2022;14:707. doi: 10.3390/cancers14030707.", "ArticleIdList": ["10.3390/cancers14030707", "PMC8833463", "35158974"]}, {"Citation": "Hoeppner J., Bronsert P. Metastasis and Tumor Cell Migration of Solid Tumors. Cancers. 2021;13:5576. doi: 10.3390/cancers13215576.", "ArticleIdList": ["10.3390/cancers13215576", "PMC8583179", "34771739"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "10", "Day": "30"}, {"Year": "2023", "Month": "11", "Day": "3"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "1", "Minute": "5"}, {"Year": "2023", "Month": "11", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["38001575", "PMC10670606", "10.3390/cancers15225315", "cancers15225315"]}}], "PubmedBookArticle": []}